Hunan Er-Kang Pharmaceutical Co., Ltd (SHE:300267)
China · Delayed Price · Currency is CNY 2.830
-0.090 (-3.08%)
Nov 13, 2026, 3:04 PM CST
SHE:300267 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Operating Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Net Income | -346.97 | -379.82 | -373.37 | -195.32 | 45.94 | -791.2 |
Depreciation & Amortization | 180.59 | 180.69 | 197.36 | 204.29 | 176.49 | 197.09 |
Other Amortization | 3.8 | 3.71 | 3.45 | 7.81 | 5.28 | 2.26 |
Loss (Gain) From Sale of Assets | -0.31 | -0.31 | -0.2 | -8.8 | -0.05 | -0.23 |
Asset Writedown & Restructuring Costs | 311.56 | 311.56 | 237.41 | 12.91 | 0 | 703.18 |
Loss (Gain) From Sale of Investments | 18.17 | 18.17 | 55.58 | 8.53 | -18.88 | -18.84 |
Provision & Write-off of Bad Debts | -2.27 | -2.27 | 1.39 | 62.85 | 7.56 | -11.54 |
Other Operating Activities | -181.71 | 37.16 | 18.28 | 29.46 | 1.73 | 208.2 |
Change in Accounts Receivable | 2.48 | 2.48 | -21.89 | -19.96 | -9.11 | 125.94 |
Change in Inventory | 42.03 | 42.03 | 66.64 | 46.97 | -111.76 | -161 |
Change in Accounts Payable | 27.71 | 27.71 | -35.61 | 8.58 | 76.47 | 35.93 |
Change in Other Net Operating Assets | -12.99 | -12.99 | 15.35 | -18.47 | 133.6 | -137.98 |
Operating Cash Flow | 71.67 | 257.68 | 166.69 | 148.42 | 281.02 | 92.68 |
Operating Cash Flow Growth | -76.31% | 54.59% | 12.31% | -47.19% | 203.20% | -18.33% |
Investing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Capital Expenditures | -237.03 | -163.98 | -195.6 | -238.19 | -173.49 | -349.33 |
Sale of Property, Plant & Equipment | 1.94 | 1.74 | 0.18 | 20.11 | 0.4 | 1.24 |
Cash Acquisitions | - | - | - | - | - | -60.55 |
Divestitures | - | - | - | - | 1.42 | 3.31 |
Investment in Securities | 205 | 30 | -119.77 | 100.35 | -100 | 354.93 |
Other Investing Activities | 4.05 | 3.78 | -6.97 | 12.81 | 13.09 | 17.22 |
Investing Cash Flow | -26.04 | -128.47 | -322.15 | -104.92 | -258.58 | -33.18 |
Financing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Short-Term Debt Issued | - | 671.34 | 546.08 | 341 | 376.75 | 396 |
Total Debt Issued | 904.03 | 671.34 | 546.08 | 341 | 376.75 | 396 |
Short-Term Debt Repaid | - | -597.7 | -401 | -380.13 | -246 | -613 |
Long-Term Debt Repaid | - | -2.92 | -5.52 | -3.36 | -5.07 | -3.32 |
Lease Payments | -2.92 | -2.92 | -5.52 | -3.36 | -5.07 | -3.32 |
Total Debt Repaid | -719.91 | -600.62 | -406.52 | -383.5 | -251.07 | -616.32 |
Net Debt Issued (Repaid) | 184.12 | 70.72 | 139.56 | -42.5 | 125.68 | -220.32 |
Issuance of Common Stock | 0.75 | - | - | 30.59 | - | - |
Common Dividends Paid | -9.88 | -11.09 | -8.42 | -70.1 | -4.73 | -114.92 |
Other Financing Activities | -117.35 | -91.16 | 10 | -84 | -130.33 | -0.01 |
Financing Cash Flow | 57.64 | -31.54 | 141.14 | -166.01 | -9.37 | -335.25 |
Net Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Foreign Exchange Rate Adjustments | -3.57 | -3.36 | -6.41 | 0.2 | 18.3 | -2.98 |
Net Cash Flow | 99.7 | 94.31 | -20.73 | -122.3 | 31.37 | -278.72 |
Free Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Free Cash Flow | -165.36 | 93.7 | -28.91 | -89.77 | 107.53 | -256.65 |
Free Cash Flow Growth | - | - | - | - | - | - |
Free Cash Flow Margin | -14.96% | 8.04% | -2.54% | -5.03% | 5.75% | -11.48% |
Free Cash Flow Per Share | -0.08 | 0.04 | -0.01 | -0.04 | 0.05 | -0.12 |
Levered Free Cash Flow | -0.69 | 119.91 | -14.38 | 15.77 | 36.83 | -65.62 |
Unlevered Free Cash Flow | 0.17 | 125.14 | -8.95 | 19.94 | 40.48 | -59.82 |
Free Cash Flow After Leases | -168.28 | 90.78 | -34.43 | -93.13 | 102.46 | -259.97 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Cash Income Tax Paid | 41.04 | 44.26 | 43.32 | 58.01 | -3.22 | 70.54 |
Change in Working Capital | 88.81 | 88.81 | 26.79 | 26.7 | 62.96 | -196.24 |